| Literature DB >> 36188869 |
Tina Backmann1, Thomas Maribo2,3, Ann-Dorthe Zwisler1, Jesper Rømhild Davidsen4,5, Nina Rottmann1,6.
Abstract
COVID-19 can lead to a long-term loss of functioning, which may affect activities and participation in daily living in various ways. The extent and characteristics of post-COVID-19 persistent symptoms are currently being studied extensively worldwide. The purpose of this exploratory study is to explore functioning and rehabilitation needs among persons with self-reported disability following COVID-19. This mixed methods study is based on data from patient-reported outcome measures (PRO), tests of body functions, visual drawings and focus groups among persons with self-reported disability after having suffered from COVID-19. PRO covered quality of life, activity and participation. Tests of body functions targeted strength and endurance. Focus groups and visual drawings elaborated on how post COVID-19 persistent symptoms affected functioning, activities and daily living. Data was collected in August and September 2020. The study sample consisted of 11 women, nine men, aged 35-79 years. Self-reported PRO data showed low quality of life and disability among the participants primarily related to fatigue, energy and drive, breathing and concentration. Tests of body functions showed low strength in lower extremities but otherwise no striking limitations on a group level. Analysis of the focus groups generated the following four themes: (1) Persistent symptoms, particularly in regards to concentration, memory, lack of energy, fatigue and headaches. (2) Balancing activities in daily living with fluctuating symptoms. (3) Uncertainty and Powerlessness, which included a need for directional guidance in order to regain functioning and unmet needs regarding further clinical assessment of persistent symptoms, referral to rehabilitation and returning to work. (4) Hope associated with the experiences of recovery - and for the future. This study highlights that persons with persistent symptoms after COVID-19 may experience a range of limitations in their daily living. This points toward a need for individual assessment and guidance to tailor relevant rehabilitation.Entities:
Keywords: COVID-19; ICF; disability; functioning; mixed methods; persistent symptoms; quality of life; rehabilitation
Year: 2021 PMID: 36188869 PMCID: PMC9397916 DOI: 10.3389/fresc.2021.710410
Source DB: PubMed Journal: Front Rehabil Sci ISSN: 2673-6861
Participant characteristics (N = 20).
|
|
|
|
|
|---|---|---|---|
|
| |||
| Women | 11 (55) | ||
| Men | 9 (45) | ||
| Age in years | 51.5 (46–68.5) | 35–79 | |
|
| |||
| <3 years of education or no education exceeding primary school (6–16 years of age) | 9 (45) | ||
| ≥3 years of education following primary school | 11 (55) | ||
|
| |||
| Retired | 7 (35) | ||
| Full- or part time employment | 9 (45) | ||
| On sick leave | 4 ( | ||
|
| |||
| 03–04/2020 | 16 (80) | ||
| 05–06/2020 | 4 (20) | ||
|
| |||
| Yes | 15 (75) | ||
| No | 5 (25) | ||
| Days admitted to hospital ( | 23 (10–30) | 1–58 | |
IQR, interquartile range.
REHPA scale of rehabilitation needs (N = 19).
|
|
| |
|---|---|---|
|
|
|
|
|
|
|
|
| Practical issues | <5 | |
| Work- or school related issues | Own expectations | 6 (30) |
| Psychological issues | Worried | 9 (45) |
| Physical issues | Headache | 8 (40) |
| Vertigo | 7 (35) | |
| Balance | 8 (40) | |
| Fatigue | 16 (80) | |
| Exhaustion | 13 (65) | |
| Memory | 9 (45) | |
| Concentration | 10 (50) | |
| Impaired mobility | 5 ( | |
| Decreased muscle strength | 8 (40) | |
| Muscle- and joint pain | 8 (40) | |
| Breathing | 11 (55) | |
| Paraesthesia | 5 ( | |
| Family issues | 0 | |
| Spiritual or religious issues | 0 |
IQR, interquartile range.
Scales of functioning and health related quality of life (N = 20).
|
|
|
| ||
|---|---|---|---|---|
| PCFS | 2 (2, 3) | 1–4 | ||
| EQ-5D-5L | 60 (50–65) | 15–75 | ||
|
| ||||
| Mobility | No problems | 11 (55) | ||
| Problems | 9 (45) | |||
| Self-care | No problems | 15 (75) | ||
| Problems | 5 (25) | |||
| Usual activity | No problems | 0 (0) | ||
| Problems | 20 (100) | |||
| Pain/discomfort | No problems | 3 (15) | ||
| Problems | 17 (85) | |||
| Anxiety/ depression | No problems | 6 (30) | ||
| Problems | 14 (70) | |||
IQR, interquartile range; PCFS, post COVID-19 functional status scale; EQ-5D-5L, EuroQuol 5D five level scale.
Tests of body functions (N = 20).
|
|
|
|
| |
|---|---|---|---|---|
| Age, median (IQR) | 48 (44–52) | 35–66 | 72 (55.5–75) | 38–79 |
| 30 s-STS, median (IQR) | 14 (12–24) | 7–30 | 16 (12–18.5) | 11–31 |
|
| ||||
| Right | 33.1 (27.0–35.0) | 23.9–41.8 | 37.6 (28.1–41.75) | 24.5–44.8 |
| Left | 30.1 (26.2–36.1) | 19.5–38.4 | 37.0 (30.7–44.0) | 29.1–48.6 |
|
| ||||
| Distance (meters) | 510 (450–552) | 400–623 | 565 (442.5–587.5) | 378–630 |
| Percent of reference | 95.5 (82.7–103.3) | 73.7–119.3 | 95.5 (83.3–115.7) | 80.1–116.5 |
IQR, Interquartile range; 30 s-STS, 30 second Sit To Stand test; HGS, hand grip strength; 6 MWD, 6-minute walk distance.
Figure 1Overview of symptoms marked on the timeline drawings in the focus groups (N = 19). * <5 participants experienced these symptoms in both “acute phase” and “today.” ** <5 participants experienced these symptoms in “acute phase.” *** <5 participants also experienced these symptoms “today.”